Paper Details
- Home
- Paper Details
Original Abstract of the Article :
L-timolol has been used successfully in the treatment of glaucoma. Because of its powerful beta blocking activity, however, more and more side effects have been reported. D-timolol, an optic isomer of L-timolol with much less beta blocking activity, was noted to have similar ocular hypotensive effec...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://doi.org/10.1089/jop.1989.5.271
データ提供：米国国立医学図書館（NLM）
D-Timolol: A Promising Antiglaucoma Agent with Reduced Side Effects
Glaucoma, a serious eye condition, affects millions around the world. This study examines the potential of D-timolol, an optical isomer of L-timolol, as a new treatment for glaucoma. The authors compare the ocular hypotensive effects of D-timolol with those of L-timolol, highlighting D-timolol's potential to provide similar therapeutic benefits with fewer side effects. Their research offers valuable insights into the potential of D-timolol as a promising alternative for glaucoma management.
D-Timolol Demonstrates Comparable Ocular Hypotensive Effects with Fewer Side Effects
This study provides compelling evidence for the potential of D-timolol as a promising alternative for glaucoma treatment. D-timolol effectively reduced intraocular pressure, demonstrating comparable ocular hypotensive effects to L-timolol, while exhibiting significantly less beta-blocking activity. These findings suggest that D-timolol may offer a more favorable therapeutic profile, potentially minimizing the occurrence of side effects associated with L-timolol.
Exploring New Avenues for Glaucoma Treatment
This study underscores the ongoing search for safer and more effective treatments for glaucoma. D-timolol's promising profile suggests a potential shift in glaucoma management, potentially offering a more favorable therapeutic option for patients. As we continue to delve into the complexities of glaucoma, the pursuit of new and innovative treatments remains a crucial endeavor.
Dr.Camel's Conclusion
Like a desert oasis offering respite from the scorching sun, D-timolol emerges as a potential beacon of hope for individuals facing glaucoma. This study showcases the potential of D-timolol to provide effective treatment while minimizing side effects. By exploring new avenues for glaucoma management, we can continue to improve the lives of those affected by this vision-threatening condition.
Date :
- Date Completed 1990-04-26
- Date Revised 2019-10-29
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.